1. Home
  2. NKTX vs PMTS Comparison

NKTX vs PMTS Comparison

Compare NKTX & PMTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.66

Market Cap

198.2M

Sector

Health Care

ML Signal

HOLD

Logo CPI Card Group Inc.

PMTS

CPI Card Group Inc.

HOLD

Current Price

$28.04

Market Cap

220.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTX
PMTS
Founded
2015
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
220.7M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
NKTX
PMTS
Price
$2.66
$28.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$11.33
$27.67
AVG Volume (30 Days)
589.3K
90.6K
Earning Date
05-11-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
11.88
N/A
EPS
N/A
0.34
Revenue
N/A
$312,189,000.00
Revenue This Year
N/A
$9.95
Revenue Next Year
N/A
$10.02
P/E Ratio
N/A
$80.88
Revenue Growth
N/A
12.27
52 Week Low
$1.70
$10.81
52 Week High
$3.72
$31.25

Technical Indicators

Market Signals
Indicator
NKTX
PMTS
Relative Strength Index (RSI) 60.57 67.70
Support Level $2.59 $16.21
Resistance Level $2.81 $31.25
Average True Range (ATR) 0.15 1.80
MACD 0.06 -0.03
Stochastic Oscillator 98.37 68.30

Price Performance

Historical Comparison
NKTX
PMTS

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About PMTS CPI Card Group Inc.

CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit segment, which principally produce secure debit and credit cards and provide card services for U.S. card-issuing financial institutions, including personalization, instant issuance and other payment solutions such as digital push provisioning for mobile wallets; Prepaid Debit, which provides secure packaging solutions, Prepaid Debit Cards, and other integrated prepaid card services to prepaid program managers in the U.S.; and other: principally corporate expenses. The firm generates key revenue from Debit and Credit segment.

Share on Social Networks: